Cargando…

A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness

Detalles Bibliográficos
Autores principales:	Mei, Song, Huang, Yixuan, Zhao, Yan, Zhang, Xinlei, Zhang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203536/ https://www.ncbi.nlm.nih.gov/pubmed/37218089 http://dx.doi.org/10.1002/ctm2.1262

Ejemplares similares

Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
por: Li, Baihui, et al.
Publicado: (2020)

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
por: Yang, Yue, et al.
Publicado: (2020)

Genomic alterations in KMT2 family predict outcome of immune checkpoint therapy in multiple cancers
por: Zhang, Peng, et al.
Publicado: (2021)

Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations
por: Choi, Hongyoon, et al.
Publicado: (2018)

Implementing National Digital Health Blueprint in India-The future opportunities and challenges
por: Bhattacharya, Sudip, et al.
Publicado: (2022)

Immunogenomic alterations of head and neck squamous cell carcinomas stratified by smoking status
por: Huang, Yixuan, et al.
Publicado: (2021)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
por: Jiang, Tao, et al.
Publicado: (2020)

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
por: Ju, Mingyi, et al.
Publicado: (2020)

Implications of pseudogenes for the prognosis of hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
por: Yu, Yingyan, et al.
Publicado: (2023)

The Heidelberg cardio-oncology unit (COUNT)—a possible blueprint for improved care of cardio-oncological patients
por: Lehmann, L. H., et al.
Publicado: (2021)

Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
por: Wang, Jun, et al.
Publicado: (2019)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

A pan‐cancer analysis reveals genetic alterations, molecular mechanisms, and clinical relevance of m(5)C regulators
por: Du, E, et al.
Publicado: (2020)

Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas
por: Wang, Hesong, et al.
Publicado: (2022)

Pan endocrine curriculum
por: Lodha, Sailesh, et al.
Publicado: (2015)

Alteration of serum markers in COVID‐19 and implications on mortality
por: Liu, Dan, et al.
Publicado: (2020)

High affinity monoclonal antibody targeting Siglec-15 for cancer immunotherapy
por: He, Fei, et al.
Publicado: (2021)

A blueprint for improving undergraduate education in intensive care medicine
por: O’Connor, Enda, et al.
Publicado: (2016)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
por: Qian, Junbin, et al.
Publicado: (2020)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers
por: Zhao, Yan, et al.
Publicado: (2022)

An integrative pan‐cancer analysis of the molecular and biological features of glycosyltransferases
por: Li, Yin, et al.
Publicado: (2022)

The Blueprint
por: Conant, Douglas
Publicado: (2020)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
por: Liu, Xiaodi, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

A transcriptional blueprint for a spiral-cleaving embryo
por: Chou, Hsien-Chao, et al.
Publicado: (2016)

Express.js blueprints
por: Augarten, Ben, et al.
Publicado: (2015)

SARS‐CoV‐2‐related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan‐cancers
por: Li, Xue‐Ping, et al.
Publicado: (2021)

Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019)

Somatic mutations in homologous recombination pathway predict favourable prognosis after immunotherapy across multiple cancer types
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identification of the crosstalk among four types of adenosine‐related RNA modification in pan‐cancer
por: Zhang, Shichao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1cldvtnb9dhba81f88g7r1cea